Company Monitoring Page for AstraZeneca

latest headlines for company on cafepharma

Patent Expirations Of Crestor And Zetia And The Impact On Other Cholesterol Drugs
Forbes
Mon, 01/18/16 - 08:26 pm
Tags:
patents, Crestor, Zetia, AstraZeneca, Merck
Incyte and AstraZeneca Announce New Lung Cancer Clinical Trial Collaboration
Yahoo
Mon, 01/11/16 - 08:34 am
Tags:
Incyte, AstraZeneca, lung cancer, clinical trials, INCB39110, JAK inhibitors
Eli Lilly's diabetes pill takes market share from J&J, Astra
Yahoo/Reuters
Tue, 01/5/16 - 09:16 pm
Tags:
Eli Lilly, JNJ, AstraZeneca, diabetes, Jardiance
AstraZeneca Spins Out Women's Health Treatment to $62M Startup, Millendo
Forbes
Tue, 01/5/16 - 09:42 am
Tags:
AstraZeneca, Women's Health, Millendo Therapeutics, PCOS, R&D
Dr. Reddy’s to change the color of its generic heartburn drug Nexium
Stat
Mon, 01/4/16 - 12:11 pm
Tags:
Dr Reddy's, generics, Nexium, AstraZeneca
Is AstraZeneca a Better Suitor for Relypsa Than Sanofi?
Bidness, ETC
Mon, 12/28/15 - 10:03 am
Tags:
AstraZeneca, Relypsa, Sanofi, Merck, M&A
Is AbbVie's Growth Story Falling to Pieces?
Motley Fool
Sat, 12/26/15 - 12:01 pm
Tags:
AbbVie, Humira, AstraZeneca, Acerta Pharma, acalabrutinib
AstraZeneca May Acquire Relypsa for $46/Share; Stock Surges
Bidness, ETC
Thu, 12/24/15 - 10:24 am
Tags:
AstraZeneca, Relypsa, M&A
The year's top pharma marketing controversies
Medical Marketing and Media
Wed, 12/23/15 - 09:50 pm
Tags:
FDA, drug pricing, Amarin, social media, PBMs, AstraZeneca, Pfizer, Valeant Pharmaceuticals, drug ads, Afrezza
AstraZeneca bags FDA OK on gout drug lesinurad as safety doubts linger
Fierce Biotech
Wed, 12/23/15 - 11:14 am
Tags:
AstraZeneca, FDA, lesinurad, gout
The Right Drug For Big Pharma: Precision M&A
Seeking Alpha
Tue, 12/22/15 - 10:55 am
Tags:
M&A, AstraZeneca, GSK, JNJ, Novartis, Sanofi
AstraZeneca's Acerta deal could put the hurt on AbbVie's Imbruvica
Fierce Pharma Marketing
Tue, 12/22/15 - 10:40 am
Tags:
AstraZeneca, Acerta, AbbVie, M&A, Imbruvica
Boehringer grabs 'breakthrough,' plots pivotal trials for rival to AstraZeneca, Clovis
Fierce Biotech
Mon, 12/21/15 - 10:50 am
Tags:
Boehringer Ingelheim, breakthrough therapies, BI1482694, AstraZeneca, Clovis Oncology, non-small cell lung cancer
Are Gilead Sciences, AstraZeneca Deals a Threat to AbbVie?
Bidness, ETC
Sun, 12/20/15 - 04:45 pm
Tags:
Gilead Sciences, AstraZeneca, AbbVie, filgotinib, Acerta Pharma, Galapagos
AstraZeneca hit with setback as durvalumab falls further behind on lung cancer
Fierce Biotech
Sat, 12/19/15 - 11:28 am
Tags:
AstraZeneca, durvalumab, PDL-1 inhibitors, lung cancer
Why AstraZeneca Acquired Majority Stake in Acerta?
Bidness, ETC
Thu, 12/17/15 - 09:44 am
Tags:
AstraZeneca, Acerta Pharma, M&A, acalabrutinib
AstraZeneca, Gilead Drug License Deals Could Pinch AbbVie Growth
TheStreet.com
Thu, 12/17/15 - 09:40 am
Tags:
AstraZeneca, Gilead Sciences, AbbVie, Acerta Pharma, Galapagos
AstraZeneca buys most of Acerta for $4 bln to add cancer drug
Yahoo/Reuters
Thu, 12/17/15 - 09:29 am
Tags:
AstraZeneca, Acerta Pharma, M&A, acalabrutinib
AstraZeneca supercharging its Asia strategy with WuXi and Takeda deals
Fierce Pharma
Wed, 12/16/15 - 03:47 pm
Tags:
AstraZeneca, Asia, WuXi, Takeda, R&D, China
AstraZeneca (AZN) Stock Down in Pre-Market Trading on Possible Acerta Pharma Acquisition
TheStreet.com
Mon, 12/14/15 - 10:58 am
Tags:
Acerta Pharma, AstraZeneca

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.